New Zealand markets closed

Huntsman Corporation (HUN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
23.44+0.19 (+0.82%)
At close: 04:00PM EDT
23.44 0.00 (0.00%)
After hours: 06:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.06B
Enterprise value 5.99B
Trailing P/E N/A
Forward P/E 57.14
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.69
Price/book (mrq)1.29
Enterprise value/revenue 1.00
Enterprise value/EBITDA 17.01

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 3-8.90%
S&P500 52-week change 326.24%
52-week high 329.90
52-week low 322.14
50-day moving average 324.30
200-day moving average 324.58

Share statistics

Avg vol (3-month) 31.72M
Avg vol (10-day) 31.9M
Shares outstanding 5173M
Implied shares outstanding 6173M
Float 8162.63M
% held by insiders 15.74%
% held by institutions 186.62%
Shares short (15 May 2024) 44.15M
Short ratio (15 May 2024) 42.32
Short % of float (15 May 2024) 42.54%
Short % of shares outstanding (15 May 2024) 42.40%
Shares short (prior month 15 Apr 2024) 45.15M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 44.27%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 34.14%
5-year average dividend yield 42.99
Payout ratio 4180.00%
Dividend date 328 Jun 2024
Ex-dividend date 414 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -1.49%
Operating margin (ttm)-0.95%

Management effectiveness

Return on assets (ttm)0.88%
Return on equity (ttm)-0.68%

Income statement

Revenue (ttm)5.98B
Revenue per share (ttm)34.21
Quarterly revenue growth (yoy)-8.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)-78M
Diluted EPS (ttm)-0.45
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)552M
Total cash per share (mrq)3.19
Total debt (mrq)2.49B
Total debt/equity (mrq)73.25%
Current ratio (mrq)1.55
Book value per share (mrq)18.31

Cash flow statement

Operating cash flow (ttm)300M
Levered free cash flow (ttm)184.25M